Seres Therapeutics (MCRB) Operating Margin (2016 - 2026)
Seres Therapeutics' Operating Margin was -2890.35% in Q2 2026, up 2949.59 percentage points from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Operating Margin (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Seres Therapeutics' Operating Margin was -4462.77% through Jun 30, 2026; for FY2025, it was -11910.14%.
- Operating Margin shows a five-year change of -11644.81 percentage points (FY2020 to FY2025).
- In earlier years, Operating Margin was -2524.05% in FY2022 (-2479.55 pp) and -44.50% in FY2021 (+220.83 pp).
- The Q2 2026 figure marks the highest quarterly Operating Margin since Q2 2023.
- The best year-over-year quarter for Operating Margin over five years was Q2 2023 (a gain of 5246.81 percentage points); the worst was Q3 2023 (a drop of 12666.35 percentage points).
- Per Business Quant data, MCRB's Operating Margin in the three quarters before Q2 2026 was -5839.94% (Q1 2026), -4423.97% (Q4 2025) and -6403.70% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | Seres Therapeutics | 22.42 Mn | -116.41 Mn | - | -2,890.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,890.35% |
| Mar 31, 2026 | -5,839.94% |
| Dec 31, 2025 | -4,423.97% |
| Sep 30, 2025 | -6,403.70% |
| Sep 30, 2023 | -14,382.58% |
| Jun 30, 2023 | 39.16% |
| Mar 31, 2023 | -13,518.77% |
| Dec 31, 2022 | -177.54% |
| Sep 30, 2022 | -1,716.23% |
| Jun 30, 2022 | -5,207.65% |
| Mar 31, 2022 | -3,734.16% |
| Dec 31, 2021 | -684.56% |
| Sep 30, 2021 | 53.98% |
| Jun 30, 2021 | -914.73% |
| Mar 31, 2021 | -617.80% |
| Dec 31, 2020 | -101.90% |
| Sep 30, 2020 | -2,116.80% |
| Jun 30, 2020 | -339.87% |
| Mar 31, 2020 | -240.47% |
| Dec 31, 2019 | -251.80% |
API Access
Seres Therapeutics Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();